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Reduction of blood culture contamination
rate by an educational intervention
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ABSTRACT
The efficacy of an educational intervention to
prevent blood culture contamination (BCC) in
internal medicine was studied in two medical
wards in a busy tertiary-care hospital in which
blood cultures were obtained by physicians rather
than dedicated phlebotomists. Baseline BCC rates
were 5.7% and 7.1% in intervention and control
wards, respectively (p 0.6), compared with 1.95%
and 6.7%, respectively, post-intervention
(p < 0.001). Following multivariate analysis, only
an absence of intervention was an independent
variable associated with BCC. Thus simple edu-
cational intervention reduced BCC in internal
medicine and was considered to be cost-effective.
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Blood culture contamination (BCC) is common,
accounting for up to 50% of positive blood
cultures (BCs) [1,2] and 6% of BCs overall [3–5].
BCC leads to unnecessary therapy, prolonged
stay and additional costs (> 3300 Euros ⁄ episode)
[6,7]. Contamination results from the introduction
of exogenous bacteria into BCs from the patient’s
skin, the hands of personnel, contaminated
fomites (needle, syringe, culture bottle) or during
laboratory processing. Thus, staff education plays
a central role in BCC prevention.
The study was performed at a 1000-bed ter-
tiary-care hospital where BCs were obtained by
physicians rather than dedicated phlebotomists.
Baseline BCC rates in six medical wards were
studied prospectively (May–June 2003). The inter-
vention was performed by an infection control
nurse in one ward selected randomly (Ward 1). A
second ward selected randomly (Ward 2) served
as a control. The wards were similar in terms of
the skills of staff, patient volume (2306 vs.
2347 ⁄ year), mean occupancy (110% vs. 108%),
median stay (4.5 vs. 4.2 days) and median patient
age (62 vs. 61 years). Patients were allocated
randomly to wards.
Staff education was performed on a one-to-one
basis, and proper technique was ensured via
observation. New personnel were instructed
within £ 24 h of arrival. Repeated sessions were
performed if more than three BCC episodes were
linked to a single staff member. The protocol used
included: hand-rubs for 15 s with ethanol 70%
v ⁄v plus chlorhexidine 0.5% v ⁄ v (ET-CH); use of
disposable gloves; vein palpation before disinfec-
tion; skin disinfection with ET-CH for more than
three, and preferably ten (to ensure a sufficient
contact time), outward strokes; disinfection of
bottle injection ports with ET-CH; introduction of
10 mL of blood into bottles without needle
exchange; and hand-rubs with ET-CH following
glove disposal.
The first peripheral BC obtained from every
inpatient (and subsequent cultures from the same
episode) was analysed. For each BC, the gender
and status of the responsible staff member were
recorded. A sample of 814 BCs from each ward
was required to detect a 3% difference in BCC
rates with 80% power and a 95% CI. Standard
aerobic ⁄ anaerobic sets were processed automat-
ically (Bactec 9240; Becton-Dickinson, Towson,
MD, USA). Positive vials were processed by
standard microbiological procedures. Every
positive BC was reviewed blind by an infectious
disease specialist and classified as a true-positive
or as BCC. BCC was defined as growth of typical
contaminants from one or two bottles during an
insignificant febrile episode, with no growth from
other cultures or sites, and in the absence of
vascular devices. Contaminants included coagu-
lase-negative staphylococci, Micrococcus spp.,
Propionibacterium acnes, viridans streptococci,
Bacillus spp. and non-JK corynebacteria. Data
were analysed using EpiInfo 2004 (CDC, Atlanta,
GA, USA). Frequencies were compared by chi-
square test, and a multivariate analysis was
performed using stepwise-forward logistic-
regression to eliminate confounding variables.
Pre-intervention, 1420 BCs were obtained from
six wards (180–290 ⁄ward). BCC rates were 4.6%
to 9% (6.5% overall). Baseline rates for Wards 1
and 2 were 5.7% and 7.1%, respectively (p 0.6).
During the 8-month period post-intervention,
1618 BCs were available for analysis (817 and
801 ⁄ward, respectively). BCs were taken by male
staff members from 58.3% of patients on Ward 1,
and from 81.6% on Ward 2 (p < 0.001, OR 3.2).
The status of staff members is shown in Table 1.
In Ward 1, BCs were less likely to be obtained by
interns, and more likely to be obtained by senior
and rotating physicians. Following intervention,
BCC rates were 1.9% and 6.7%, respectively
(p < 0.0001, OR 0.28); thus BCC rates in Ward 1
declined from 5.7% to 1.9% (p 0.001, OR 0.33).
The species causing BCC are shown in Table 2.
Coagulase-negative staphylococci were twice as
common on Ward 2, whereas Micrococcus and
Bacillus spp. were more prevalent on Ward 1.
True bloodstream infection accounted for 30
(3.6%) and 36 (4.5%) of cultures (p 0.4).
To eliminate confounding variables, such as
staff member gender and status, a multivariate
analysis was performed. Significant variables in
univariate analysis were entered into the model
(gender, status and ward type). Ward type (i.e.,
Table 1. Status of staff members who obtained blood
culture specimens during the post-intervention period
(Ward 1, intervention ward; Ward 2, control ward)
Status Ward 1 (n = 817) Ward 2 (n = 801) p value (OR)
Medical student 128 (15.5%) 112 (14%) 0.3
Intern 550 (67%) 588 (73.5%) 0.007 (0.75)
Resident 75 (9%) 75 (9%) 0.9
Senior physician 15 (2%) 4 (0.5%) 0.012 (3.7)
Rotating physician 49 (6%) 22 (3%) 0.0014 (2.3)
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absence of intervention) was the only variable
associated significantly with BCC (p 0.003, OR 2.5,
95% CI 1.4–4.6).
Skin disinfection is central to the prevention of
BCC, but the optimal disinfection method has not
yet been determined. Potential disinfectants in-
clude povidone-iodine (PI), isopropyl-alcohol
(IPA), iodine tincture (TI), ET and CH. Alcohols
appear more efficacious than iodophors in some
[8,9] but not all studies [10], and TI appears
superior to PI in others [4,5,7]. Only two studies of
BCC have used CH; one showed reduced BCC
with alcohol plus CH 0.5% v ⁄ v compared with PI
10% v ⁄ v [11], while the other reported no differ-
ence between CH 2% v ⁄ v plus IPA 70% v ⁄ v and
TI 2% v ⁄ v plus IPA 70% v ⁄ v [12]. The present
study used ET plus CH, since its use was thought
more likely to increase compliance, as iodophors
[11,13] and higher CH concentrations [14] have
been associated with dermatitis. Additional fac-
tors, such as foam generation and staining of
clothes may also influence compliance. All disin-
fection procedures in the protocol (hand-rub, skin
and culture bottle disinfection) were performed
conveniently with the same preparation, which
might also be expected to increase compliance.
The required contact time for BCC prevention
during skin disinfection is unknown, but staff
were instructed to disinfect the skin of patients
with more than three, and preferably up to ten
applications, to increase contact time. However,
this was not monitored prospectively, and it was
not established whether this recommendation
was beneficial.
Only limited data are available concerning the
association between the expertise of staff members
and the risk of BCC. Previous studies have shown
that trained phlebotomists are associated with
lower BCC rates than resident physicians [4,15,16].
In the present study, the gender and status of
personnel were not associated independently with
BCC, and younger physicians performed no worse
than those with more experience.
The study has several limitations. First, no two
wards are identical, and thus differences in
practice could have influenced the results. The
similarity between wards, random ward selection
and patient allocation, blind BCC review and
multivariate analysis diminish the likelihood for
bias, but cannot eliminate it completely. Second,
only the first set of cultures obtained from each
patient was investigated. This approach may
create a selection bias, since not all cultures were
studied, although it has the advantage of increas-
ing sample homogeneity. Future studies should
also examine the incidence of BCC in a longitud-
inal manner.
In conclusion, a protocol utilising ET-CH
decreased the BCC rate significantly. Utilisation
of a single disinfectant may increase compliance,
but ET-CH should be compared with other
preparations in randomised controlled trials.
Since each BCC episode results in additional costs
of > 3300 Euros (roughly the monthly salary of a
nurse), appointment of a full-time infection con-
trol nurse may be cost-effective, even if only one
BCC episode is prevented monthly. The protocol
described above should be considered for use
when BCC rates are significant in settings that do
not employ dedicated phlebotomists.
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